GGrantIndex
Sort

326,823 grants matching clinical trial

ADULT AIDS CLINICAL TRIALS UNIT

$1,587,829
Susan L Koletar · Ohio State University · U01 · FY2006 · AI

Minnesota Heart Survey - Renewal

$1,587,813
Russell V Luepker · University Of Minnesota · R01 · FY2008 · HL

Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age

$1,587,757
Debra Ellyn Weese-Mayer · Lurie Children'S Hospital Of Chicago · R01 · FY2025 · HL

Pragmatic Trial of Population-based Programs to Prevent Suicide Attempt

$1,587,679
Gregory E Simon · Kaiser Foundation Health Plan Of Washington · UH3 · FY2017 · MH

Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease

$1,587,671
Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2022 · AG

Expression Genetics in Drug Therapy

$1,587,669
Wolfgang Sadee · Ohio State University · U01 · FY2014 · GM

Gene Therapy Approaches for Primary Immunodeficiencies

$1,587,410
Fabio Candotti · National Human Genome Research Institute · ZIA · FY2009 · HG

CREST-2 Statistical and Data Coordinating Center - SDCC

$1,587,333
George Howard · University Of Alabama At Birmingham · U01 · FY2021 · NS

THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT

$1,587,049
Oklahoma Medical Research Foundation · P50 · FY2002 · HL

A Controlled Trial of CBT for MS Inflammation

$1,586,954
Northern California Institute Res &Educ · R01 · FY2005 · HD

NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites

$1,586,915
Carolyn Y Muller · University Of New Mexico Health Scis Ctr · UG1 · FY2024 · CA

Expression Genetics in Drug Therapy

$1,586,888
Wolfgang Sadee · Ohio State University · U01 · FY2012 · GM

Analgesic Drug for Local Delivery by Fluoroscopy

$1,586,882
Andreas S Beutler · Interventional Analgesix, Inc. · R44 · FY2020 · NS

A multi-center trial to improve nocturia and sleep in older adults

$1,586,879
Elizabeth Camille Vaughan · Emory University · RF1 · FY2025 · AG

Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents

$1,586,646
Howard H Bailey · University Of Wisconsin-Madison · N01 · FY2011 · CA

African American Eye Disease Study

$1,586,633
Rohit Varma · University Of Southern California · U10 · FY2017 · EY

CRANIOFACIAL COMPLEMENTARY &ALTERNATIVE MEDICINE CENTER

$1,586,572
Kaiser Foundation Research Institute · P50 · FY2001 · AT

DIAN-TU Primary Prevention Trial

$1,586,508
Eric Martin McDade · Washington University · U01 · FY2021 · AG

Primary Care Screening and Intervention for Elder Neglect in Patients with Dementia: An Evidence-Based Approach

$1,586,496
Anthony Rosen · Weill Medical Coll Of Cornell Univ · R33 · FY2025 · AG

Metabolic regulation of T cell effector function and anti-tumor immunotherapy

$1,586,326
Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System

$1,586,315
Teresa K Woodruff · Northwestern University At Chicago · UH3 · FY2014 · TR

NHGRI/DIR Cytogenetics and Microscopy Core

$1,586,224
Amalia Dutra · National Human Genome Research Institute · ZIC · FY2020 · HG

Integrative Molecular Epidemiology of Human Cancer

$1,586,024
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Molecular Targets for Drug and Radiation Sensitivity

$1,585,979
University Of Pennsylvania · P01 · FY2005 · CA

Mouse Allergen and Asthma Intervention Trial

$1,585,874
Elizabeth C. Matsui · Johns Hopkins University · U01 · FY2012 · AI